Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease
This study provides a proof-of-concept for the design of a novel theranostic integration strategy for concomitant IBD treatment and the real-time monitoring of treatment responses.
Authors
- Lin Cao (ORCID: https://orcid.org/0009-0003-1775-4570)
- Dengyi Duan
- Shuang Liu (ORCID: https://orcid.org/0000-0002-4372-8443)
- Yiming Li
- Wenyi Zhang (ORCID: https://orcid.org/0000-0003-1985-9002)
- Jian-Min Li (ORCID: https://orcid.org/0009-0004-3304-8796)
- Yunfei Guo (ORCID: https://orcid.org/0009-0009-0360-8429)
- Xuening Zhang (ORCID: https://orcid.org/0000-0003-2686-7465)
- Kangkang Liu
- Yang Zhao (ORCID: https://orcid.org/0000-0003-2282-2120)
- Jing Peng (ORCID: https://orcid.org/0000-0002-4893-2697)
- Qi Cao (ORCID: https://orcid.org/0000-0001-6970-8654)
- Xinwen Li
- Ruinan Li (ORCID: https://orcid.org/0000-0001-6937-4324)
Institutions
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
- Second Hospital of Tianjin Medical University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Journal of Nanobiotechnology
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1186/s12951-024-02749-1
- Citations
- 31
- Primary Topic
- Advanced Nanomaterials in Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 3.63
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- Tianjin Medical University
- Tianjin Municipal Education Commission
- Second Hospital of Tianjin Medical University
- Science Fund for Distinguished Young Scholars of Tianjin